What is it about?
The book chapter "Biomarker Discovery—Approaches and Agonies" by Dr. Debprasad Dutta evaluates the technological methods used to identify biological clues for early disease detection and the clinical challenges of translating these findings into real-world medical tests. It details multi-omics and high-throughput toolkits alongside the reproducibility crises and validation obstacles that hinder clinical adoption. For more details, visit
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
1. Stopping the "Reproducibility Crisis" Researchers must address issues such as flawed statistics and poor sample handling early in the discovery phase to prevent clinical trial failures, given that fewer than 1% of laboratory-discovered biomarkers reach clinical use. 2. Unlocking Precision Medicine Integrating multiple biological layers enables the identification of specific molecular clues, facilitating tailored patient treatments that replace traditional one-size-fits-all approaches. 3. Boosting Drug Success Rates Properly validated biomarkers allow pharmaceutical developers to quickly identify drug efficacy and toxicity, significantly reducing research time and development costs. You can learn more about these insights by visiting the original source: https://www.taylorfrancis.com/chapters/edit/10.1201/9781003456384-9/biomarker-discovery%E2%80%94approaches-agonies-debprasad-dutta
Perspectives
This chapter addresses the critical bottleneck preventing laboratory-discovered biomarkers from reaching clinical use by emphasizing the need to correct foundational statistical and sample-handling errors early in the discovery phase. It outlines how integrating multiple biological layers enables precision medicine through tailored patient treatments and highlights how validated biomarkers can mitigate high failure rates and reduce development costs in pharmaceutical research. You can read the full analysis in your chapter. Check out more here: https://researchid.co/debprasaddutta
Dr. DEBPRASAD DUTTA
The Walton Centre NHS Foundation Trust
Read the Original
This page is a summary of: Biomarker Discovery—Approaches and Agonies, July 2026, Taylor & Francis,
DOI: 10.1201/9781003456384-9.
You can read the full text:
Resources
Contributors
The following have contributed to this page
